Dr Reddy's Labs lines up Rs 1,500 cr capex with focus on biosimilars, injectables

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses, according to CFO Parag Agarwal. The Hyderabad-based drug...

India's Cipla beats estimates with 11% rise in quarterly profit

Indian drugmaker Cipla Ltd reported a bigger-than-expected 11% increase in second-quarter profit on Friday, helped by rising demand for its drugs and inhalers and a boost in its new ventures...

Pfizer-BioNTech to test combined Covid and flu vaccine

Pfizer-BioNTech said Pfizer-BioNTech to test combined Covid and flu vaccinethey will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses...

How Startups are Disrupting the Pharma Industry

How pharmaceutical industry is growing rapidly owing to technological innovations and what are some of the innovative solutions the pharmaceutical start-ups have come up with.

USFDA approves Alembic's Ketorolac tromethamine injection USP

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL,...

Indegene to Aid AstraZeneca scale up omnichannel operations across the globe

Indegene, life sciences commercialisation company, announced that it is helping AstraZeneca scale up its omnichannel operations across the globe with an aim to create a more personalised customer experience....

Alembic Pharma gets approval from USFDA for Mesalamine extended-release capsules

Alembic pharmaceutical company received final approval from the US Food & Drug Administration (USFDA) for Abbreviated New Drug Application (ANDA)...

Glenmark Pharma receives approval from the US health regulator for a generic drug

Glenmark Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market Sodium Phenylbutyrate tablets, used in treating urea ...

Solara Active Pharma Sciences Vizag Plant Receives European Approval (CEP) to Produce Ibuprofen API

Solara Active Pharma Sciences Limited, a pure play Active Pharmaceutical Ingredient provider has announced that its new state-of-the-art multipurpose API...

Akums, Microcore Research enter JV to develop NESM dietary supplements

Akums Drugs & Pharmaceuticals Ltd has entered into a joint venture with Microcore Research. With this tie-up, Akums will now leverage natural eggshell membrane (NESM) and develop dietary supplements for maintaining healthy joint and connective...

© 2025 India Pharma Outlook. All Rights Reserved.